Barclays’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $222K | Sell |
63,180
-1,063,977
| -94% | -$3.4M | ﹤0.01% | 3634 |
|
|
2025
Q4 | $3.08M | Buy |
1,127,157
+190,470
| +20% | +$441K | ﹤0.01% | 2620 |
|
|
2025
Q3 | $2.03M | Buy |
936,687
+52,347
| +6% | +$124K | ﹤0.01% | 2873 |
|
|
2025
Q2 | $1.52M | Buy |
884,340
+313,504
| +55% | +$780K | ﹤0.01% | 3059 |
|
|
2025
Q1 | $1.9M | Sell |
570,836
-46,967
| -8% | -$242K | ﹤0.01% | 2674 |
|
|
2024
Q4 | $4.57M | Buy |
617,803
+13,219
| +2% | +$123K | ﹤0.01% | 2242 |
|
|
2024
Q3 | $5.68M | Buy |
604,584
+328,284
| +119% | +$3.11M | ﹤0.01% | 1983 |
|
|
2024
Q2 | $2.22M | Buy |
276,300
+20,947
| +8% | +$224K | ﹤0.01% | 2062 |
|
|
2024
Q1 | $3.78M | Sell |
255,353
-580,822
| -69% | -$6.76M | ﹤0.01% | 2049 |
|
|
2023
Q4 | $6.8M | Buy |
836,175
+78,224
| +10% | +$409K | ﹤0.01% | 1838 |
|
|
2023
Q3 | $3.45M | Buy |
757,951
+228,359
| +43% | +$1.49M | ﹤0.01% | 1550 |
|
|
2023
Q2 | $3.73M | Buy |
529,592
+112,432
| +27% | +$805K | ﹤0.01% | 1518 |
|
|
2023
Q1 | $2.55M | Sell |
417,160
-213,790
| -34% | -$1.48M | ﹤0.01% | 2012 |
|
|
2022
Q4 | $4.03M | Buy |
630,950
+240,344
| +62% | +$1.88M | ﹤0.01% | 1773 |
|
|
2022
Q3 | $3.74M | Buy |
390,606
+347,191
| +800% | +$4M | ﹤0.01% | 1342 |
|
|
2022
Q2 | $479K | Sell |
43,415
-29,849
| -41% | -$391K | ﹤0.01% | 2894 |
|
|
2022
Q1 | $1.22M | Buy |
73,264
+67,312
| +1,131% | +$1.04M | ﹤0.01% | 2245 |
|
|
2021
Q4 | $114K | Sell |
5,952
-24,938
| -81% | -$549K | ﹤0.01% | 3702 |
|
|
2021
Q3 | $761K | Sell |
30,890
-59,373
| -66% | -$1.4M | ﹤0.01% | 2945 |
|
|
2021
Q2 | $2.35M | Buy |
90,263
+21,869
| +32% | +$568K | ﹤0.01% | 2084 |
|
|
2021
Q1 | $2.17M | Buy |
68,394
+1,821
| +3% | +$75.5K | ﹤0.01% | 2206 |
|
|
2020
Q4 | $3.09M | Buy |
66,573
+7,617
| +13% | +$302K | ﹤0.01% | 1890 |
|
|
2020
Q3 | $1.94M | Sell |
58,956
-133,423
| -69% | -$4.09M | ﹤0.01% | 2129 |
|
|
2020
Q2 | $5.28M | Buy |
192,379
+70,563
| +58% | +$2.32M | 0.01% | 1338 |
|
|
2020
Q1 | $3.65M | Sell |
121,816
-87,865
| -42% | -$2.33M | 0.01% | 1737 |
|
|
2019
Q4 | $5.8M | Buy |
209,681
+104,169
| +99% | +$2.37M | 0.01% | 1853 |
|
|
2019
Q3 | $1.92M | Buy |
105,512
+30,578
| +41% | +$676K | ﹤0.01% | 2917 |
|
|
2019
Q2 | $1.84M | Buy |
74,934
+18,906
| +34% | +$285K | ﹤0.01% | 3025 |
|
|
2019
Q1 | $534K | Buy |
+56,028
| New | +$544K | ﹤0.01% | 4047 |
|
|
2018
Q4 | – | Sell |
-47,860
| Closed | -$539K | – | 7124 |
|
|
2018
Q3 | $539K | Buy |
47,860
+34,846
| +268% | +$495K | ﹤0.01% | 4208 |
|
|
2018
Q2 | $167K | Sell |
13,014
-4,247
| -25% | -$62.1K | ﹤0.01% | 4863 |
|
|
2018
Q1 | $291K | Sell |
17,261
-18,538
| -52% | -$281K | ﹤0.01% | 4478 |
|
|
2017
Q4 | $286K | Buy |
35,799
+32,563
| +1,006% | +$261K | ﹤0.01% | 4383 |
|
|
2017
Q3 | $25K | Buy |
3,236
+3,196
| +7,990% | +$20.2K | ﹤0.01% | 5699 |
|
|
2017
Q2 | $0 | Sell |
40
-1,417
| -97% | -$9.01K | ﹤0.01% | 6781 |
|
|
2017
Q1 | $11K | Sell |
1,457
-1,212
| -45% | -$8.88K | ﹤0.01% | 6046 |
|
|
2016
Q4 | $18K | Sell |
2,669
-12,437
| -82% | -$85.6K | ﹤0.01% | 5668 |
|
|
2016
Q3 | $124K | Sell |
15,106
-61,821
| -80% | -$523K | ﹤0.01% | 4347 |
|
|
2016
Q2 | $623K | Buy |
76,927
+76,632
| +25,977% | +$481K | ﹤0.01% | 3019 |
|
|
2016
Q1 | $1K | Sell |
295
-509
| -63% | -$2.79K | ﹤0.01% | 5969 |
|
|
2015
Q4 | $5K | Buy |
804
+569
| +242% | +$3.95K | ﹤0.01% | 5570 |
|
|
2015
Q3 | $1K | Sell |
235
-626
| -73% | -$4.88K | ﹤0.01% | 6546 |
|
|
2015
Q2 | $8K | Buy |
+861
| New | +$9.61K | ﹤0.01% | 6197 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM